Inflammatory Skin Diseases of the Vulva and Perianal Region
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants voluntarily consented to the study and signed an informed consent for; 2. Female, aged 18 <= age <= 70 years. 3. It meets the diagnostic criteria for sclerosing caress, chronic simple caress or atopic dermatitis. 4. All systemic and topical treatments were discontinued 10 weeks prior to trial initiation.
Exclusion criteria
Exclusion criteria: 1. Patients with infectious diseases such as candidal infection, bacterial vaginosis, gonorrhea, or non-gonococcal urethritis; 2. Those with diabetes, chronic liver disease, chronic kidney disease, or autoimmune diseases; 3. Pregnant or breastfeeding women; 4. Patients using immunosuppressants or immunomodulatory drugs for other conditions; 5. Individuals deemed unsuitable for the trial by the investigator; 6. Those unable to attend regular follow-ups, who have not signed the informed consent form, or who have mental health conditions such as anxiety disorders or obsessive-compulsive disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCORAD Score at Week 8; | — |
Secondary
| Measure | Time frame |
|---|---|
| Weekly SCORAD Score from Week 1 to Week 7;Relapse Rate at 6 Months Post-Treatment; | — |
Countries
China
Contacts
ZhuJiang Hospital of Southern Medical University